Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

NEW HCV RNA Linearity Panel from LGC

Products are for professional/laboratory use only.

Abacus dx is pleased to inform you about the NEW HCV RNA Linearity Panel available from LGC.

The AccuSpan™ HCV RNA Linearity Panel 2410-0327 is intended to be used in evaluating the dynamic range of quantitative HCV RNA assays. It is an eight member panel made from serial dilutions of high titter recombinant hepatitis C virus. This panel can be used for monitoring HCV RNA recovery at defined intervals, identifying consistency over a linear range, verifying lot changes, performing linearity studies, or whenever there are indications of possible assay deterioration.
 
This new panel was formulated using LGC’s propriety AccuPlex™ technology, which produces a replicative deficient, fully packaged virus which is heat treated as an added precaution.
 
Regulatory Status: For Research Use Only. Not for use in diagnostic procedures.

 

View the Data Sheet

Download Now >

View the Package Insert

Download Now >

View the SeraCare Product Catalogue >

Download Now >

Request a quote

Contact Us Now >



Request a Quote

Request Quote

Recent Posts

Savyon – SeroFIA™ Chlamydia

The Gold Standard in Chlamydia Serodiagnostics with High Sensitivity and User-Friendly Design The SeroFIA™ Chlamydia product line by Savyon Diagnostics consists of specific Microimmunofluorescence assays (MIF)…

Read full article

Certest – Clostidium Difficile Rapid Test

Simplifying C. difficile Screening with Certest Rapid Tests Certest provides a diverse range of rapid tests designed for simple yet highly sensitive screening assays, enabling…

Read full article

Vircell – Aspergillus Galactomannan Ag VirClia® Monotest

Meet the Aspergillus Galactomannan Ag Virclia® Monotest The reliable result, just when you need it Rapid, on‑demand detection of invasive aspergillosis — no batching, no delays,…

Read full article